Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Cardoso, F. ; Paluch-Shimon, S. ; Senkus, E. ; Curigliano, G. ; Aapro, M.S. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Bhattacharyya, G.S. ; Biganzoli, L. ; Boyle, F. ; Cardoso, M.-J. ; Carey, L.A. ; Cortés, J. ; El Saghir, N.S. ; Elzayat, M. ; Eniu, A. ; Fallowfield, L. ; Francis, P.A. ; Gelmon, K. ; Gligorov, J. ; Haidinger, R. ; Harbeck, N. ; Hu, X. ; Kaufman, B. ; Kaur, R. ; Kiely, B.E. ; Kim, S.-B. ; Lin, N.U. ; Mertz, S.A. ; Neciosup, S. ; Offersen, B.V. ; Ohno, S. ; Pagani, O. ; Prat, A. ; Penault-Llorca, F. ; Rugo, H.S. ; Sledge, G.W. ; Thomssen, C. ; Vorobiof, D.A. ; Wiseman, T. ; Xu, B. ; Norton, L. ; Costa, A. ; Winer, E.P.Annals of oncology, 2020-12, Vol.31 (12), p.1623-1649 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Cardoso, F ; Senkus, E ; Costa, A ; Papadopoulos, E ; Aapro, M ; André, F ; Harbeck, N ; Aguilar Lopez, B ; Barrios, C H ; Bergh, J ; Biganzoli, L ; Boers-Doets, C B ; Cardoso, M J ; Carey, L A ; Cortés, J ; Curigliano, G ; Diéras, V ; El Saghir, N S ; Eniu, A ; Fallowfield, L ; Francis, P A ; Gelmon, K ; Johnston, S R D ; Kaufman, B ; Koppikar, S ; Krop, I E ; Mayer, M ; Nakigudde, G ; Offersen, B V ; Ohno, S ; Pagani, O ; Paluch-Shimon, S ; Penault-Llorca, F ; Prat, A ; Rugo, H S ; Sledge, G W ; Spence, D ; Thomssen, C ; Vorobiof, D A ; Xu, B ; Norton, L ; Winer, E PAnnals of oncology, 2018-08, Vol.29 (8), p.1634-1657 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Prospective Validation of a 21-Gene Expression Assay in Breast CancerSparano, Joseph A ; Gray, Robert J ; Makower, Della F ; Pritchard, Kathleen I ; Albain, Kathy S ; Hayes, Daniel F ; Geyer, Charles E ; Dees, Elizabeth C ; Perez, Edith A ; Olson, John A ; Zujewski, JoAnne ; Lively, Tracy ; Badve, Sunil S ; Saphner, Thomas J ; Wagner, Lynne I ; Whelan, Timothy J ; Ellis, Matthew J ; Paik, Soonmyung ; Wood, William C ; Ravdin, Peter ; Keane, Maccon M ; Gomez Moreno, Henry L ; Reddy, Pavan S ; Goggins, Timothy F ; Mayer, Ingrid A ; Brufsky, Adam M ; Toppmeyer, Deborah L ; Kaklamani, Virginia G ; Atkins, James N ; Berenberg, Jeffrey L ; Sledge, George WThe New England journal of medicine, 2015-11, Vol.373 (21), p.2005-2014 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Research needs in breast cancerCardoso, F. ; Harbeck, N. ; Barrios, C.H. ; Bergh, J. ; Cortés, J. ; El Saghir, N. ; Francis, P.A. ; Hudis, C.A. ; Ohno, S. ; Partridge, A.H. ; Sledge, G.W. ; Smith, I.E. ; Gelmon, K.A.Annals of oncology, 2017-02, Vol.28 (2), p.208-217 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Abemaciclib with fulvestrant in patients with HR+, HER2- advanced breast cancer (ABC) that exhibited primary or secondary resistance to prior endocrine therapy (ET)Grischke, E.-M ; Neven, P ; Lin, Y ; Kaufman, P.A ; Sledge, G.WAnn Oncol, 2018-10, Vol.29 Suppl 8, p.viii106 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
241P Abemaciclib plus fulvestrant in participants with HR+/HER2- advanced breast cancer: A pooled analysis of the endocrine therapy naïve (EN) participants in MONARCH 2Luis-Gonzalez Trujillo, J. ; Escobar Gomez, M. ; Sohn, J.H. ; Im, Y-H. ; Wang, H-C. ; Llombart Cussac, A. ; Zhang, W. ; Haddad, N. ; Wasserstrom, H. ; van Hal, G. ; Sledge, G.W.Annals of oncology, 2021-09, Vol.32, p.S464-S465 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Effects of vitamin D3 on proliferation of cancer cells in vitroFIFE, R. S ; SLEDGE, G. W ; PROCTOR, CCancer letters, 1997-11, Vol.120 (1), p.65-69 [Periódico revisado por pares]Shannon: ElsevierTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Abemaciclib with fulvestrant in patients with HR+, HER2- advanced breast cancer (ABC) that exhibited primary or secondary resistance to prior endocrine therapy (ET)Grischke, E.-M. ; Neven, P. ; Lin, Y. ; Kaufman, P.A. ; Sledge, G.W.Annals of oncology, 2018-10, Vol.29, p.viii106-viii106 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
185 INVITED Inhibiting angiogenesis–anew weapon in the therapeutic armamentariumMiller, K ; Sledge, G.WEuropean journal of cancer supplements, 2007, Vol.5 (4), p.49-49 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Clinical outcomes by chemotherapy regimen in patients with RS 26-100 in TAILORxSparano, J. ; Gray, R.J. ; Makower, D. ; Albain, K. ; Saphner, T.J. ; Badve, S. ; Wagner, L. ; Mihalcioiu, C. ; Desbiens, C. ; Hayes, D.F. ; Dees, E.C. ; Geyer, C. ; Olson, J. ; Wood, W.C. ; Lively, T. ; Paik, S. ; Ellis, M. ; Abrams, J.S. ; Sledge, G.W.Annals of oncology, 2019-10, Vol.30, p.v854 [Periódico revisado por pares]Texto completo disponível |